[Ossen Innovation Announces Formation of Special Committee to Evaluate Proposed Transaction SHANGHAI, August 4, 2016 /PRNewswire/ -- Ossen Innovation Co., Ltd. ("Ossen Innovation" or the "Company") (Nasdaq: OSN), a China-based manufacturer of an array of plain surface, rare earth and zinc coated pre-stressed steel materials, today announced that the Company’s Board of Directors, with the unanimous agreement of all directors,] []
[Seaspan Corporation nd Unit 2, 2 141 Connaught Road West Hong Kong, China c/o 2600 200 Granville Street Vancouver, BC Canada V6C 1S4 Tel: 604-638-2575 Fax: 604-648-9782 www.seaspancorp.com Seaspan Announces Pricing of $225 Million Public Offering of 7.875% Series H Cumulative Redeemable Perpetual Preferred Shares HONG KONG, CHINA, August 4, 2016 Seaspan Corporation (Seaspan) (NYSE:SSW) announced today that] [Item 1 Information Contained in this Form 6-K Report SEASPAN CORPORATION David Spivak Chief Financial Officer (Principal Financial and Accounting Officer) 6-K 1 d208866d6k.htm FORM 6-K]
[Ossen Innovation Announces Formation of Special Committee to Evaluate Proposed Transaction SHANGHAI, August 4, 2016 /PRNewswire/ -- Ossen Innovation Co., Ltd. ("Ossen Innovation" or the "Company") (Nasdaq: OSN), a China-based manufacturer of an array of plain surface, rare earth and zinc coated pre-stressed steel materials, today announced that the Company’s Board of Directors, with the unanimous agreement of all directors,] []
[Seaspan Corporation nd Unit 2, 2 141 Connaught Road West Hong Kong, China c/o 2600 200 Granville Street Vancouver, BC Canada V6C 1S4 Tel: 604-638-2575 Fax: 604-648-9782 www.seaspancorp.com Seaspan Announces Pricing of $225 Million Public Offering of 7.875% Series H Cumulative Redeemable Perpetual Preferred Shares HONG KONG, CHINA, August 4, 2016 Seaspan Corporation (Seaspan) (NYSE:SSW) announced today that] [Item 1 Information Contained in this Form 6-K Report SEASPAN CORPORATION David Spivak Chief Financial Officer (Principal Financial and Accounting Officer) 6-K 1 d208866d6k.htm FORM 6-K]
[FORM 6-K August 2016 001-35722 CHINA INFORMATION TECHNOLOGY, INC. 21 st Floor, Everbright Bank Building Zhuzilin, Futian District Shenzhen, Guangdong, 518040 Peoples Republic of China Note Note: On July 29, 2016, Mr. Guanguyuan Zong resigned from his position as Chief Marketing Officer of China Information Technology, Inc. (the Company). Mr. Zongs resignation was due to personal reasons and was not]
[Seaspan Corporation nd Unit 2, 2 141 Connaught Road West Hong Kong, China c/o 2600 200 Granville Street Vancouver, BC Canada V6C 1S4 Tel: 604-638-2575 Fax: 604-648-9782 www.seaspancorp.com Seaspan Announces Public Offering of Series H Cumulative Redeemable Perpetual Preferred Shares Merrill Lynch, Pierce, Fenner & Smith Incorporated, Morgan Stanley, J.P. Morgan, RBC Capital Markets and Citigroup Global Markets Inc.] [Item 1 Information Contained in this Form 6-K Report SEASPAN CORPORATION David Spivak Chief Financial Officer (Principal Financial and Accounting Officer) 6-K 1 d226290d6k.htm FORM 6-K]
[FORM 6-K August 2016 001-35722 CHINA INFORMATION TECHNOLOGY, INC. 21 st Floor, Everbright Bank Building Zhuzilin, Futian District Shenzhen, Guangdong, 518040 Peoples Republic of China Note Note: On July 29, 2016, Mr. Guanguyuan Zong resigned from his position as Chief Marketing Officer of China Information Technology, Inc. (the Company). Mr. Zongs resignation was due to personal reasons and was not]
[Seaspan Corporation nd Unit 2, 2 141 Connaught Road West Hong Kong, China c/o 2600 200 Granville Street Vancouver, BC Canada V6C 1S4 Tel: 604-638-2575 Fax: 604-648-9782 www.seaspancorp.com Seaspan Announces Public Offering of Series H Cumulative Redeemable Perpetual Preferred Shares Merrill Lynch, Pierce, Fenner & Smith Incorporated, Morgan Stanley, J.P. Morgan, RBC Capital Markets and Citigroup Global Markets Inc.] [Item 1 Information Contained in this Form 6-K Report SEASPAN CORPORATION David Spivak Chief Financial Officer (Principal Financial and Accounting Officer) 6-K 1 d226290d6k.htm FORM 6-K]
[FOR RELEASE August 4, 2016 China Biologic Reports Financial Results for the Second Quarter of 2016 --2Q16 Total Sales Up 23.4% with Non-GAAP Net Income Up 31.3% YoY in RMB terms, or Up 15.5% YoY to $91.4 Million and 23.1% YoY to $35.2 Million in USD terms, respectively --1H16 Total Sales Up 26.2% with Non-GAAP Net Income Up 30.6% YoY] []
[This document is in two parts. The first part is the prospectus supplement, which describes the specific terms of this offering. The second part is the accompanying base prospectus, which gives more general information, some of which may not apply to this offering. Generally, when we refer to the prospectus, we are referring to both parts combined. If information in]
